# Eli Lilly and Company (LLY) — Q3-2016 Earnings Results

**Report date:** 2016-10-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.88 | N/A | -8.05% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed caution regarding market conditions but remains focused on strategic initiatives. They acknowledged the need for continued adaptation.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized their commitment to long-term growth despite current hurdles.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Eli Lilly's earnings report indicates a slight miss on EPS, which may raise concerns among investors about profitability. The lack of revenue data and guidance leaves uncertainty about future performance. The stock reaction is not available, but the market may respond cautiously given the EPS miss and management's cautious tone.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2016_